Large-scale test of hypothesised associations between polymorphisms of lipid-related genes and myocardial infarction in about 5000 cases and 6000 controls by Keavney, B, Youngman, L, Palmer, A, Parish, S, Clark, S, Delepine, M, Lathrop, M, Peto, R, Collins, R

Large-scale test of association between myocardial infarction, plasma lipid levels and apolipoprotein E e2/e3/e4 polymorphism in about 11,000 cases and controls by Keavney, B, Youngman, L, Palmer, A, Parish, S, Clark, S, Delepine, M, Lathrop, M, Peto, R, Collins, R

Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. by Keavney, B, Danesh, J, Parish, S, Palmer, A, Clark, S, Youngman, L, Delépine, M, Lathrop, M, Peto, R, Collins, R

Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: Test of causality by "Mendelian randomisation" by Youngman, L, Keavney, B, Palmer, A, Parish, S, Clark, S, Danesh, J, Delepine, M, Lathrop, M, Peto, R, Collins, R

Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 contr... by Keavney, B, McKenzie, C, Parish, S, Palmer, A, Clark, S, Youngman, L, Delépine, M, Lathrop, M, Peto, R, Collins, R

Large-scale test of hypothesised associations between the angiotensin-1 converting enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 5000 con... by Keavney, B, McKenzie, C, Parish, S, Palmer, A, Clark, S, Youngman, L, Delepine, M, Lathrop, M, Peto, R, Collins, R

Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E epsilon2/epsilon3/epsilon4 genotype. by Keavney, B, Parish, S, Palmer, A, Clark, S, Youngman, L, Danesh, J, McKenzie, C, Delépine, M, Lathrop, M, Peto, R, Collins, R

Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E ε2/ε3/ε4 genotype by Keavney, B, Parish, S, Palmer, A, Clark, S, Youngman, L, Danesh, J, McKenzie, C, Delépine, M, Lathrop, M, Peto, R, Collins, R

Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. by Keavney, B, Palmer, A, Parish, S, Clark, S, Youngman, L, Danesh, J, McKenzie, C, Delépine, M, Lathrop, M, Peto, R, Collins, R

Polymorphisms in Type-II SH2-comain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome by Kaisaki, P, Delepine, M, Woon, P, Vionnet, N, Marion, E, Riveline, J, Charpentier, G, Schurmans, S, Levy, J, Lathrop, M, Farrall, M, Gauguier, D

Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. by Julier, C, Delépine, M, Keavney, B, Terwilliger, J, Davis, S, Weeks, D, Bui, T, Jeunemaître, X, Velho, G, Froguel, P, Ratcliffe, P, Corvol, P, Soubrier, F, Lathrop, G

Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. by Kaisaki, P, Delépine, M, Woon, P, Sebag-Montefiore, L, Wilder, S, Menzel, S, Vionnet, N, Marion, E, Riveline, J, Charpentier, G, Schurmans, S, Levy, J, Lathrop, M, Farrall, M, Gauguier, D